Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and,... see more

TSXV:MDX - Post Discussion

Medx Health Corp > Loblaw Companies Limited completes acquisition of Lifemark
View:
Post by PrairieInvestor on May 10, 2022 9:14am

Loblaw Companies Limited completes acquisition of Lifemark

FYI

2022-05-10 07:40:00 AM ET (CNW Group)
                 
                               
Loblaw Companies Limited (TSX: L) ("Loblaw") today confirmed the closing of the previously announced acquisition of Lifemark Health Group ("Lifemark") from Audax Private Equity.
 
Lifemark is a leading provider of outpatient physiotherapy, massage therapy, occupational therapy, chiropractic, mental health and other ancillary rehabilitation services in Canada. With this acquisition, Loblaw through its wholly-owned subsidiary Shoppers Drug Mart Inc., adds to its growing role as a healthcare service provider, with a network of health and wellness solutions, accessible in-person and digitally.
 
Loblaw Companies Limited is Canada's food and pharmacy leader, with a network of more than 2,400 corporate, franchised and Associate-owned locations in communities across the country. Loblaw's purpose - Live Life Well® - supports the needs and well-being of Canadians who make one billion visits each year to the company's stores.
 
Led by Shoppers Drug Mart, the leader in Canada's retail drug store marketplace and the number one provider of pharmacy products and services, Loblaw offers full-service pharmacies and a range of services like prescriptions, med checks, vaccinations, minor-ailment diagnoses, and nutrition consultations in more than 1,800 locations in 10 provinces and 2 territories, including in Shoppers Drug Mart, PharmaPrix, Loblaw pharmacy, DRUGStore Pharmacy and CENTRESante locations.
 
Lifemark Health Group is a Canadian leader in community rehabilitation, workplace health and wellness and medical assessment services. With over 20 years of service excellence, Lifemark Health Group is a comprehensive and trusted health provider with 3 million patient visits annually, and employs over 5,000 highly trained clinicians, medical experts and team members.
 
As Canada's largest physiotherapy company, Lifemark is passionate about enriching the health of Canadians through movement. Lifemark's commitment to health and wellness extends beyond patient care, to the entire team, as evidenced through an award-winning culture.
 
Audax Group is a leading alternative investment manager with offices in Boston, New York, and San Francisco. Since its founding in 1999, the firm has raised over $30 billion in capital across its Private Equity and Private Debt businesses. Audax Private Equity has invested over $9 billion in more than 150 platforms and over 1050 add-on companies, and is currently investing out of its $3.5 billion, sixth private equity fund. Through its disciplined Buy & Build approach, Audax seeks to help platform companies execute add-on acquisitions that fuel revenue growth, optimize operations, and significantly increase equity value. With more than 30 employees and over 100 investment professionals, the firm is a leading capital partner for North American middle market companies. For more information, visit the Audax Private Equity website www.audaxprivateequity.com
 
This press release may contain forward-looking information within the meaning of applicable securities legislation, which reflects Loblaw's current expectation regarding future events. There can be no assurance regarding the ability of Loblaw to successfully grow its business as described in this press release.
 
Forward-looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Loblaw's control, that could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking information. Such risks and uncertainties include, but are not limited to, the factors discussed in Loblaw's current Annual MD&A and Annual Information Form. Loblaw does not undertake any obligation to update such forward-looking information, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. All forward-looking statements contained in this press release are made as of the date hereof and are qualified by these cautionary statements.
SOURCE Loblaw Companies Limited
 
View original content to download multimedia: https://www.newswire.ca/en/releases/archive/May2022/10/c9948.html
 
SOURCE: Loblaw Companies Limited
Comment by hopefull on May 10, 2022 6:46pm
ok clearly no one is paying attention. This is a major development. If shopper wants to dominate the market with a health Division you can bet Medx will be there. This is the reason that they didn't do a deal before in my opinion. All of this is.starting to make sense.. Italy turned pilot to commericalization. I'm expecting news about the UK to be pretty much the same as Italy.. I think if ...more  
Comment by bogeyfree on May 10, 2022 10:58pm
Hey Hopefull, haven't seen you this positive in a while! I like your post but at .055, we have a long way to go and right now, I'm hopeless! Even Insightful1 has left the cheering squad or does he know something's coming and he can't talk? No, hopeless!
Comment by hopefull on May 11, 2022 5:54am
just hang tight.doing due diligence is a hell of a lot of work when the company is small and constantly hand to mouth but if you dig deep get off this continent and look and talk to other companies you can get some interest perspective especially when those companies become quiet to really good questions. I remain hopeful.cheers enjoy the ride.